Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Tissue Ageing and Senescence Markers: Study Summary

Previous related pageVitamin D, Tissue Ageing and Senescence Markers: Full Evidence ReviewNext related pageVitamin D, Tissue Ageing and Senescence Markers: Full Evidence Review
Study at a glance

What question did the studies ask?

Researchers asked whether vitamin D-related changes in cells lead to healthier ageing tissues. This review compares animal experiments, a small human skin test, blood-cell measurements and calculated biological-age scores. These studies measure different things. Senescent cells stop dividing for a long time but remain active.

What did the researchers find?

Some mouse experiments linked low active-vitamin-D signalling to bone changes. Deleting a gene that controls cell division or giving a separate drug improved selected features. Those interventions were not vitamin D3 treatment. Other experiments found worse lung injury with calcitriol, the active vitamin D hormone. The results do not establish the effects of ordinary oral vitamin D3 in people.

A small uncontrolled study found mixed changes in older adults’ skin immune responses to previously encountered viral material. A short randomized trial in older adults with low vitamin D levels found changes in selected blood-cell measurements. It did not show clear differences in blood inflammation measures or prove removal of senescent cells.

Human studies of DNA methylation clocks also gave mixed results. DNA carries genetic information. These clocks calculate age-related scores from chemical marks on DNA. The larger three-year trial did not show a clear vitamin D-alone effect on its four clocks. Positive findings for omega-3 or combined treatments cannot be assigned to vitamin D alone.

What does this mean?

These findings help investigate ageing biology. They do not establish that vitamin D rejuvenates human tissues, improves how tissues recover after stress or extends life.

Read the full article below ↓

Vitamin D-related pathways can affect selected features of ageing tissues, but the studies do not establish general rejuvenation in people. Animal experiments, skin tests, blood-cell measurements and calculated biological-age scores answer different questions. Senescent cells stop dividing for a long time but remain active; changing one associated measurement does not prove their removal. For the detailed evidence, read Vitamin D, Tissue Ageing and Senescence Markers: Full Evidence Review.

What was studied?

This review compares mouse tissue experiments and human studies. Some researchers removed the vitamin D receptor or reduced production of active vitamin D. Others gave calcitriol, the active hormone, oral vitamin D3 or a separate drug. These interventions are different. Vitamin D and Cellular Senescence explains the cell state, while Vitamin D and Age-Related Decline introduces the wider tissue-ageing question.

What did the tissue experiments find?

In mice with reduced active-vitamin-D production, researchers linked selected bone changes with a cell-cycle pathway. Removing P27, a regulator of cell division, partly improved skeletal features. A separate study reported selected improvements with navitoclax, a drug used to target senescent cells. Neither intervention was vitamin D3 treatment, and the studies came from a shared research programme. The wider skeletal setting is explained in Vitamin D and Bone. [1] [2]

A study of ovaries in mice with receptor loss throughout the body used 7-dehydrocholesterol, a substance that can be used to make vitamin D3. That was not vitamin D3 treatment or demonstrated restoration of fertility. In a lung-injury model, calcitriol worsened selected signs of fibrosis, the build-up of scar tissue, and tissue damage. These findings prevent a uniformly beneficial account but do not establish ordinary oral vitamin D3 effects in people. [3] [4]

What did the human studies show?

An uncontrolled study of 18 older adults found mixed changes in the skin’s response to previously encountered viral material after vitamin D3 treatment. A later paper reused the same human samples. This was one cohort, not two independent trials. It did not establish prevention of shingles or a reduction in senescent cells throughout the body. [5] [6]

A randomized eight-week trial studied 88 older adults with low vitamin D levels. It compared 1,000 or 5,000 international units of vitamin D3 daily, with or without a separate substance called N-acetylcysteine. Every group received vitamin D3. Higher-dose groups had lower selected blood-cell measurements than the lower dose alone, but several other measures did not show clear differences between groups. Green-stained pixel area was not a direct percentage of senescent cells. A correction confirms 5,000 rather than erroneous 50,000-unit table labels. [7] [8]

DO-HEALTH studied DNA-based age scores in 777 older Swiss participants over three years. DNA carries genetic information. These scores use selected chemical marks on DNA; they do not measure lifespan or tissue repair. Participants received different randomized combinations of vitamin D3 or placebo, omega-3 or placebo, and an exercise comparison. A placebo is an inactive comparison treatment. Vitamin D alone did not show a clear effect on its four assessed scores. Combination findings cannot be assigned to vitamin D alone. [9]

Smaller or observational studies reported mixed positive age-score findings. One involved self-selected supplement users, and another used monthly dosing in a small trial. These results show that some studies reported age-score associations or treatment differences, while others did not show clear changes. They do not establish lasting gene regulation or improvements in tissue function with ageing. [10] [11]

What does this mean?

A changed marker, a tissue structure and a measured function are different results. The evidence supports particular pathways and experimental effects, with important limits. Connections to Vitamin D and Regeneration need relevant structural or functional evidence. These studies do not establish that vitamin D makes human tissues younger, improves how tissues preserve function or recover after stress or extends life. Research regimens are not personal treatment instructions.

Scientific sources

[1] Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation. Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology. 2026;195(2):329-344. DOI 10.1093/ejendo/lvag152; PMID 42592858.

[2] The senolytic agent ABT263 ameliorates osteoporosis caused by active vitamin D insufficiency through selective clearance of senescent skeletal cells. Yang C, Qiao W, Xue Q, Goltzman D, Miao D, Dong Z. Journal of Orthopaedic Translation. 2024;49:107. DOI 10.1016/j.jot.2024.08.012; PMID 39430127; PMCID PMC11490840.

[3] Loss of vitamin D receptor induces premature ovarian insufficiency through compromising the 7-dehydrocholesterol-dependent anti-aging effects. Chen H, Wang Q, Zhang Y, Shangguan L, Zhu Z, Zhang H, Zou X, Geng Q, Wen Y, Wang D, Wang Y. Frontiers in cell and developmental biology. 2025;13:1545167. DOI 10.3389/fcell.2025.1545167; PMID 40276652; PMCID PMC12018433.

[4] Detrimental pro-senescence effects of vitamin D on lung fibrosis. Guijarro T, Magro-Lopez E, Manso J, Garcia-Martinez R, Fernandez-Aceñero MJ, Liste I, Zambrano A. Molecular medicine (Cambridge, Mass.). 2018;24(1):64. DOI 10.1186/s10020-018-0064-z; PMID 30567504; PMCID PMC6299997.

[5] Vitamin D3 replacement enhances antigen-specific immunity in older adults. Chambers ES, Vukmanovic-Stejic M, Turner CT, Shih BB, Trahair H, Pollara G, Tsaliki E, Rustin M, Freeman TC, Mabbott NA, Noursadeghi M, Martineau AR, Akbar AN. Immunotherapy Advances. 2021;1(1):ltaa008. DOI 10.1093/immadv/ltaa008; PMID 36284901; PMCID PMC9585673.

[6] Vitamin D3 inhibits p38 MAPK and senescence-associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Sayegh S, Fantecelle CH, Laphanuwat P, Subramanian P, Rustin MHA, Gomes DCO, Akbar AN, Chambers ES. Aging cell. 2024;23(4):e14093. DOI 10.1111/acel.14093; PMID 38287646; PMCID PMC11019144.

[7] Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology. 2025;16:1570441. DOI 10.3389/fimmu.2025.1570441; PMID 40421021; PMCID PMC12104082.

[8] Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology. 2025;16:1627178. DOI 10.3389/fimmu.2025.1627178; PMID 40510343.

[9] Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Bischoff-Ferrari HA, Gängler S, Wieczorek M, Belsky DW, Ryan J, Kressig RW, Stähelin HB, Theiler R, Dawson-Hughes B, Rizzoli R, Vellas B, Rouch L, Guyonnet S, Egli A, Orav EJ, Willett W, Horvath S. Nature aging. 2025;5(3):376-385. DOI 10.1038/s43587-024-00793-y; PMID 39900648; PMCID PMC11922767.

[10] Vitamin D supplementation is associated with slower epigenetic aging. Vetter VM, Sommerer Y, Kalies CH, Spira D, Bertram L, Demuth I. GeroScience. 2022;44(3):1847-1859. DOI 10.1007/s11357-022-00581-9; PMID 35562603; PMCID PMC9213628.

[11] Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial. Chen L, Dong Y, Bhagatwala J, Raed A, Huang Y, Zhu H. The journals of gerontology. Series A, Biological sciences and medical sciences. 2019;74(1):91-98. DOI 10.1093/gerona/gly223; PMID 30256915; PMCID PMC6612014.

Related reading

Original sources

Source

Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation.

Published in Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology (2026).

Publication details

[1] Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation. Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology. 2026;195(2):329-344. DOI 10.1093/ejendo/lvag152; PMID 42592858.

Read more →
Source

The senolytic agent ABT263 ameliorates osteoporosis caused by active vitamin D insufficiency through selective clearance of senescent skeletal cells.

Published in Yang C, Qiao W, Xue Q, Goltzman D, Miao D, Dong Z. Journal of Orthopaedic Translation (2024).

Publication details

[2] The senolytic agent ABT263 ameliorates osteoporosis caused by active vitamin D insufficiency through selective clearance of senescent skeletal cells. Yang C, Qiao W, Xue Q, Goltzman D, Miao D, Dong Z. Journal of Orthopaedic Translation. 2024;49:107. DOI 10.1016/j.jot.2024.08.012; PMID 39430127; PMCID PMC11490840.

Read more →
Source

Loss of vitamin D receptor induces premature ovarian insufficiency through compromising the 7-dehydrocholesterol-dependent anti-aging effects.

[3] Loss of vitamin D receptor induces premature ovarian insufficiency through compromising the 7-dehydrocholesterol-dependent anti-aging effects.

Publication details

[3] Loss of vitamin D receptor induces premature ovarian insufficiency through compromising the 7-dehydrocholesterol-dependent anti-aging effects. Chen H, Wang Q, Zhang Y, Shangguan L, Zhu Z, Zhang H, Zou X, Geng Q, Wen Y, Wang D, Wang Y. Frontiers in cell and developmental biology. 2025;13:1545167. DOI 10.3389/fcell.2025.1545167; PMID 40276652; PMCID PMC12018433.

Read more →
Source

Detrimental pro-senescence effects of vitamin D on lung fibrosis

The multiple biological effects of vitamin D and its novel activities on inflammation and redox homeostasis have raised high expectations on its use as a therapeutic agent for multiple fibrogenic conditions.

Publication details

[4] Detrimental pro-senescence effects of vitamin D on lung fibrosis. Guijarro T, Magro-Lopez E, Manso J, Garcia-Martinez R, Fernandez-Aceñero MJ, Liste I, Zambrano A. Molecular medicine (Cambridge, Mass.). 2018;24(1):64. DOI 10.1186/s10020-018-0064-z; PMID 30567504; PMCID PMC6299997.

Read more →
Source

Vitamin D3 replacement enhances antigen-specific immunity in older adults

We investigated the use of vitamin D3 replacement to enhance cutaneous antigen-specific immunity in older adults (≥65 years).

Publication details

[5] Vitamin D3 replacement enhances antigen-specific immunity in older adults. Chambers ES, Vukmanovic-Stejic M, Turner CT, Shih BB, Trahair H, Pollara G, Tsaliki E, Rustin M, Freeman TC, Mabbott NA, Noursadeghi M, Martineau AR, Akbar AN. Immunotherapy Advances. 2021;1(1):ltaa008. DOI 10.1093/immadv/ltaa008; PMID 36284901; PMCID PMC9585673.

Read more →
Source

Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing

Vitamin D3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity.

Publication details

[6] Vitamin D3 inhibits p38 MAPK and senescence-associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Sayegh S, Fantecelle CH, Laphanuwat P, Subramanian P, Rustin MHA, Gomes DCO, Akbar AN, Chambers ES. Aging cell. 2024;23(4):e14093. DOI 10.1111/acel.14093; PMID 38287646; PMCID PMC11019144.

Read more →
Source

Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial.

Published in Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology (2025).

Publication details

[7] Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology. 2025;16:1570441. DOI 10.3389/fimmu.2025.1570441; PMID 40421021; PMCID PMC12104082.

Read more →
Source

Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial

Published in Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology (2025).

Publication details

[8] Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology. 2025;16:1627178. DOI 10.3389/fimmu.2025.1627178; PMID 40510343.

Read more →
Source

Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.

[9] Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.

Publication details

[9] Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Bischoff-Ferrari HA, Gängler S, Wieczorek M, Belsky DW, Ryan J, Kressig RW, Stähelin HB, Theiler R, Dawson-Hughes B, Rizzoli R, Vellas B, Rouch L, Guyonnet S, Egli A, Orav EJ, Willett W, Horvath S. Nature aging. 2025;5(3):376-385. DOI 10.1038/s43587-024-00793-y; PMID 39900648; PMCID PMC11922767.

Read more →
Source

Vitamin D supplementation is associated with slower epigenetic aging

We previously reported on an association between vitamin D deficiency and higher 7-CpG DNAmAA in participants of the Berlin Aging Study II (BASE-II).

Publication details

[10] Vitamin D supplementation is associated with slower epigenetic aging. Vetter VM, Sommerer Y, Kalies CH, Spira D, Bertram L, Demuth I. GeroScience. 2022;44(3):1847-1859. DOI 10.1007/s11357-022-00581-9; PMID 35562603; PMCID PMC9213628.

Read more →
Source

Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial.

[11] Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial.

Publication details

[11] Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial. Chen L, Dong Y, Bhagatwala J, Raed A, Huang Y, Zhu H. The journals of gerontology. Series A, Biological sciences and medical sciences. 2019;74(1):91-98. DOI 10.1093/gerona/gly223; PMID 30256915; PMCID PMC6612014.

Read more →